<DOC>
	<DOC>NCT00378560</DOC>
	<brief_summary>A study to evaluate the efficacy, immunogenicity, safety and tolerability of V501 in adult women</brief_summary>
	<brief_title>V501 Efficacy Study in Women Aged 18 to 26 (V501-027)</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Female Subject Aged 18 To 26 Years With 14 Lifetime Sexual Partners Male Subject</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>26 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>